Your browser doesn't support javascript.
loading
Risk Factors for the Development of Bullous Pemphigoid in US Patients Receiving Immune Checkpoint Inhibitors.
Said, Jordan T; Liu, Mofei; Talia, Jordan; Singer, Sean B; Semenov, Yevgeniy R; Wei, Erin X; Mostaghimi, Arash; Nelson, Caroline A; Giobbie-Hurder, Anita; LeBoeuf, Nicole R.
Afiliação
  • Said JT; Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts.
  • Liu M; Harvard Medical School, Boston, Massachusetts.
  • Talia J; Division of Biostatistics, Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Singer SB; Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts.
  • Semenov YR; Harvard Medical School, Boston, Massachusetts.
  • Wei EX; Department of Dermatology, Massachusetts General Hospital, Boston.
  • Mostaghimi A; Harvard Medical School, Boston, Massachusetts.
  • Nelson CA; Department of Dermatology, Massachusetts General Hospital, Boston.
  • Giobbie-Hurder A; Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts.
  • LeBoeuf NR; Harvard Medical School, Boston, Massachusetts.
JAMA Dermatol ; 158(5): 552-557, 2022 05 01.
Article em En | MEDLINE | ID: mdl-35416925
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male Idioma: En Ano de publicação: 2022 Tipo de documento: Article